drugset / Trial / NCT00630019

Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator

NCT00630019

Phase 4 Completed 96 enrolled Santen Inc. Vistakon Pharmaceuticals · collab
RandomizedParallel-groupSingle-blindBasic science

Summary

Compare ocular tissue levels following topical ocular instillation of 1.5% levofloxacin ophthalmic solution or an active comparator in subjects undergoing cataract surgery.

Timeline

Start
2008-02
Primary completion
2008-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 1.5 % Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical

Indications